SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/15/21 Thermo Fisher Scientific Inc. 8-K:8,9 4/15/21 12:359K Cravath Swaine & … 01/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 48K 2: EX-99.1 Joint Press Release HTML 28K 8: R1 Document and Entity Information HTML 86K 10: XML IDEA XML File -- Filing Summary XML 12K 7: XML XBRL Instance -- form8-k_htm XML 57K 9: EXCEL IDEA Workbook of Financial Reports XLSX 7K 4: EX-101.DEF XBRL Definitions -- tmo-20210415_def XML 66K 5: EX-101.LAB XBRL Labels -- tmo-20210415_lab XML 101K 6: EX-101.PRE XBRL Presentations -- tmo-20210415_pre XML 72K 3: EX-101.SCH XBRL Schema -- tmo-20210415 XSD 24K 11: JSON XBRL Instance as JSON Data -- MetaLinks 19± 27K 12: ZIP XBRL Zipped Folder -- 0000950157-21-000419-xbrl Zip 25K
i Delaware
|
i 04-2209186
|
|||
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
i ☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
||
i ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
||
i ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
||
i ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
i Common Stock, $1.00 par value
|
i TMO
|
i New York Stock Exchange
|
||
i 2.150% Notes due 2022
|
i TMO 22A
|
i New York Stock Exchange
|
||
i 0.750% Notes due 2024
|
i TMO 24A
|
i New York Stock Exchange
|
||
i 0.125% Notes due 2025
|
i TMO 25B
|
i New York Stock Exchange
|
||
i 2.000% Notes due 2025
|
i TMO 25
|
i New York Stock Exchange
|
||
i 1.400% Notes due 2026
|
i TMO 26A
|
i New York Stock Exchange
|
||
i 1.450% Notes due 2027
|
i TMO 27
|
i New York Stock Exchange
|
||
i 1.750% Notes due 2027
|
i TMO 27B
|
i New York Stock Exchange
|
||
i 0.500% Notes due 2028
|
i TMO 28A
|
i New York Stock Exchange
|
||
i 1.375% Notes due 2028
|
i TMO 28
|
i New York Stock Exchange
|
||
i 1.950% Notes due 2029
|
i TMO 29
|
i New York Stock Exchange
|
||
i 0.875% Notes due 2031
|
i TMO 31
|
i New York Stock Exchange
|
||
i 2.375% Notes due 2032
|
i TMO 32
|
i New York Stock Exchange
|
||
i 2.875% Notes due 2037
|
i TMO 37
|
i New York Stock Exchange
|
||
i 1.500% Notes due 2039
|
i TMO 39
|
i New York Stock Exchange
|
||
i 1.875% Notes due 2049
|
i TMO 49
|
i New York Stock Exchange
|
Exhibit No.
|
Description
|
||
104
|
Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.
|
THERMO FISHER SCIENTIFIC INC. | ||||
Date: April 15, 2021
|
By:
|
/s/ Michael A. Boxer | ||
Name: | Michael A. Boxer |
|||
Title: | Senior Vice President and General Counsel |
|||
Exhibit No.
|
Description
|
||
99.1
|
Joint Press Release of Thermo Fisher Scientific Inc. and PPD, Inc., dated April 15, 2021.
|
||
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 4/15/21 | 8-K | ||
12/31/20 | 10-K, 11-K, 4, SD | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/10/21 Thermo Fisher Scientific Inc. 424B5 1:983K Donnelley … Solutions/FA 11/08/21 Thermo Fisher Scientific Inc. 424B5 1:956K Donnelley … Solutions/FA 10/20/21 Thermo Fisher Scientific Inc. 424B5 1:881K Donnelley … Solutions/FA 10/19/21 Thermo Fisher Scientific Inc. 424B5 1:827K Donnelley … Solutions/FA 10/07/21 Thermo Fisher Scientific Inc. 424B5 1:904K Donnelley … Solutions/FA 10/04/21 Thermo Fisher Scientific Inc. 424B5 1:883K Donnelley … Solutions/FA 8/10/21 Thermo Fisher Scientific Inc. 424B5 1:755K Donnelley … Solutions/FA 8/09/21 Thermo Fisher Scientific Inc. 424B5 1:728K Donnelley … Solutions/FA |